|
ALG11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98909777537892E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.58810000097753E-08 |
| Normal-vs-Stage2 |
2.900500E-02 |
| Normal-vs-Stage3 |
4.425500E-02 |
| Normal-vs-Stage4 |
1.482810E-01 |
| Stage1-vs-Stage2 |
5.593200E-01 |
| Stage1-vs-Stage3 |
2.583600E-01 |
| Stage1-vs-Stage4 |
3.733800E-01 |
| Stage2-vs-Stage3 |
4.667400E-01 |
| Stage2-vs-Stage4 |
2.318000E-01 |
| Stage3-vs-Stage4 |
1.373030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.28530005819528E-10 |
| Normal-vs-AfricanAmerican |
1.774150E-04 |
| Normal-vs-Asian |
9.463600E-01 |
| Caucasian-vs-AfricanAmerican |
6.137000E-01 |
| Caucasian-vs-Asian |
2.374400E-01 |
| AfricanAmerican-vs-Asian |
2.251200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19989995717162E-09 |
| Normal-vs-Female |
3.63420000000225E-05 |
| Male-vs-Female |
7.565200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.822100E-04 |
| Normal-vs-Extreme_Weight |
2.51839999998449E-06 |
| Normal-vs-Obese |
2.10269999967316E-07 |
| Normal-vs-Extreme_Obese |
2.035800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.763600E-01 |
| Normal_Weight-vs-Obese |
2.162200E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.958600E-01 |
| Extreme_Weight-vs-Obese |
3.637800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.202200E-01 |
| Obese-vs-Extreme_Obese |
2.652400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.398400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.3070004774346E-10 |
| Normal-vs-Age(61-80Yrs) |
7.19939999949126E-07 |
| Normal-vs-Age(81-100Yrs) |
9.598300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.226420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.159160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.855800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.326400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.966770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.182000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63079993953374E-10 |
| Normal-VS-Type2 PRCC |
1.399410E-03 |
| Normal-VS-KIRP CIMP |
6.367000E-01 |
| Normal-VS-Unclassified PRCC |
1.156350E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.219400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.164400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.546200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.176700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.344800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.270140E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.54290000000157E-05 |
| Normal-vs-N1 |
1.384770E-01 |
| Normal-vs-N2 |
4.401200E-01 |
| N0-vs-N1 |
6.597200E-01 |
| N0-vs-N2 |
6.918800E-01 |
| N1-vs-N2 |
7.494800E-01 |
|
|
